Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol disodium vs propofol for sedation in endoscopic ultrasonography
ChiCTR2500115027Phase 4Not yet recruiting
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- Dec 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium in gastrointestinal conditions (2 arms), sponsored by Cancer Hospital of Guangxi Medical University. Primary endpoint: Procedure Completion Rate. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2500115027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115027.